IMMUNOLOGY Correction for “Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo,” by Fubin Li and Jeffrey V. Ravetch, which appeared in issue 48, November 26, 2013, of Proc Natl Acad Sci USA (110:19501–19506; first published November 11, 2013; 10.1073/pnas.1319502110).
The authors note that the following statement should be added to the Acknowledgments: “This publication is also based on research supported in part by the Melanoma Research Alliance (Award ID: 235798; project title: Enhancing immunotherapeutic activity of agonistic anti-CD40 antibodies), the Harry J. Lloyd Charitable Trust, and the Cancer Research Institute CLIP grant.”